Results 101 to 110 of about 9,980 (152)

Antimicrobial Susceptibility of <i>Pseudomonas aeruginosa</i> from Elderly Patients in Intensive Care Units of United States Medical Centers (2021-2025). [PDF]

Antibiotics (Basel)
Sader HS, Mendes RE, Doyle TB, Winkler ML, Castanheira M.   +4 more
europepmc   +1 more source

Spread of carbapenemase-producing <i>Serratia</i> spp. in France from 2016 to 2024: a comparative genomic study. [PDF]

Emerg Microbes Infect
Rezzoug I, Bernabeu S, Ouacel K, Birer A, Jousset AB, Larouy-Maumus G, Bonnin RA, Emeraud C, Dortet L.   +8 more
europepmc   +1 more source

Current progress in antibacterial agents for carbapenem-resistant enterobacterales. [PDF]

Front Pharmacol
Xu W, Shang L, Li X, Yu J, Shen J, Li Y, He Q, Chen L, Wang D, Wei Y, Niu S.   +10 more
europepmc   +1 more source

Co-Administration Dosing of Ceftazidime-Avibactam and Aztreonam in Patients with Varying Renal Function for Carbapenem-Resistant Enterobacterales Infections via Monte Carlo Simulation. [PDF]

Infect Chemother
Hemapanpairoa J, Saelim W, Changpradub D, Santimaleeworagun W.   +3 more
europepmc   +1 more source

The <i>bla_KPC-249</i> -mediated mechanism drives the transition of ST463 <i>Pseudomonas aeruginosa</i> from Ceftazidime-Avibactam sensitivity to resistance during clinical treatment. [PDF]

Front Cell Infect Microbiol
Li X, Feng Y, Wu X, Shen H, Shang S, Tang W, Hu F, Liang H.   +7 more
europepmc   +1 more source

Integrated machine learning, molecular dynamics, and density functional theory approaches for identifying potential inhibitor targeting TEM 𝛽-lactamase in <i>Escherichia coli</i>. [PDF]

Front Bioinform
Roy A, Anbarasu A.
europepmc   +1 more source

In vitro activity of aztreonam–avibactam combination against blood culture isolates of Stenotrophomonas maltophilia in Japan before the launch of ceftazidime–avibactam

Microbiology Spectrum
Wataru Aoki, Yoshifumi Uwamino, Yuka Kamoshita, Rika Inose, Mika Nagata, Naoki Hasegawa, Hiromichi Matsushita   +6 more
doaj   +1 more source

Unraveling Cefiderocol Resistance in NDM- and OXA-48-like Co-Producing <i>Klebsiella pneumoniae</i> Isolates Through Integrated Genomic and Phenotypic Analysis. [PDF]

Antibiotics (Basel)
Ambretti S, Cetatean R, Secci B, Landi J, Cantiani A, Foschi C.   +5 more
europepmc   +1 more source

Synergistic Potential of Repurposing non-β-lactam Compounds as Class A serine β-lactamases Inhibitor: Insights from MolecularDocking, Molecular Dynamics Simulations and Antimicrobial Potentiation. [PDF]

Sci Rep
Abdalla MS, Dutta S, Sulieman MO, Jaber AA, Noorelhuda MO, Elkhidir OF, Sardar S, Hajhamed NM, Awad TA, Mustafa SA, Lee SG, Aldin NAM.   +11 more
europepmc   +1 more source